MarketPulse

cancer vaccine

3 articles
BenzingaBenzinga··Prnewswire

NWBO Bolsters Leadership With Veteran Pharma Executive to Expand Cancer Vaccine Platform

Northwest Biotherapeutics appoints experienced biopharma executive Dr. Annalisa Jenkins as Strategic Adviser to advance its DCVax dendritic cell cancer vaccine platform.
NWBOpersonalized medicinesolid tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Kessler Topaz Meltzer & Check, Llp

ImmunityBio Faces Securities Fraud Suit Over Anktiva Cancer Claims

ImmunityBio faces securities fraud lawsuit after FDA warning over false Anktiva claims. Stock plunged 21%. Investor deadline May 26, 2026.
IBRXsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pfizer vs. Moderna: Navigating Pharma's Post-Pandemic Pivot

Moderna's 69% YTD gain reflects mRNA vaccine upside, while Pfizer's 6.3% dividend offers stability as COVID revenues fade. Choice depends on risk appetite.
MRKPFEMRNAbiotechclinical trials